Biotech News
PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026
investors.polypid.com2026-05-06 15:28 EST
PETACH TIKVA, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter 2025 financial results and operational highlights before the